Patient Journey Mapping in Pharma: A Guide to Digital Engagement

Introduction

Patient journey mapping enables pharmaceutical brands to improve patient experiences through strategic visualization of healthcare interactions. It identifies critical touchpoints from symptom awareness to post-treatment care, helping companies align with the strict regulatory environments of the EU and Switzerland.

Adherence to healthcare regulations is crucial for successful implementation, optimizing patient engagement, innovation, and outcomes by understanding different cases within patient journeys to improve healthcare outcomes.

Understanding the Patient Journey

What is the Patient Journey?

The patient journey is the sequence of events that a patient experiences when interacting with a healthcare organization, from the initial need for care to ongoing care.

It encompasses all touchpoints of a patient’s healthcare experience, including locating healthcare providers, paying the bill, and continuing their care after treatment.

Understanding the patient journey is essential to improving the patient experience, as it helps healthcare organizations identify moments of truth: the touchpoints that have the biggest impact on patient loyalty.

Patient Journey Mapping Process

Pharmaceutical brands employ patient journey mapping to visualize and analyze patient experiences.

The methodology involves systematic processes and design frameworks to ensure comprehensive data collection and analysis. This strategic approach reveals interactions, pain points, and compliance requirements crucial in highly regulated markets like the EU and Switzerland.

Stages of the Patient Journey

Patient journeys typically encompass stages: symptom awareness, medical advice, diagnosis, treatment initiation, adherence, and post-treatment care. Recognizing and addressing symptoms throughout the patient’s care journey is crucial as it can guide treatment options, improve functional scores, and potentially affect the need for palliative care. Each stage must comply with EU (EMA) and Swiss (Swissmedic) regulatory standards, ensuring patient safety and data protection.

Creating a Patient Journey Map

Getting Started with Patient Journey Mapping

To create a patient journey map, healthcare organizations should start by engaging individuals across all departments and including input from multiple stakeholders. This involves identifying the target audience and creating robust patient profiles to segment and track like-populations.

The goal of the patient’s journey should be specified, and various touchpoints should be considered to understand how they affect the patient’s ability to meet this goal. Effective patient journey mapping requires a clear understanding of the patient’s needs and goals.

Best Practices for Creating a Patient Journey Map

When creating a patient journey map, healthcare organizations should follow best practices to ensure that the map is comprehensive and accurate.

This includes:

• Identifying all touchpoints of the patient journey, including non-clinical interactions

• Involving multiple stakeholders, including managers, doctors, nurses, and administrative staff, in the data collection process

• Capturing all steps involved in each stage of the patient journey

• Considering patient expectations and usage when collecting data

• Using analytics, benchmarking, and visualizations to gain insights from patient journey data

• Engaging all the right stakeholders when reviewing patient journey data

• Identifying gaps and opportunities for improvement using patient journey data

• Using patient journey data to develop solutions to improve the patient experience

• Implementing a closed-loop system to take action and close gaps along the patient journey

• Utilizing omnichannel distribution to gather feedback from patients across all touchpoints.

By following these best practices, healthcare organizations can create a patient journey map that provides a comprehensive view of the patient experience and helps to identify areas for improvement.

Mapping Techniques

Mapping techniques include quantitative methods like patient surveys, Electronic Health Records (EHRs), and insurance claims, alongside qualitative feedback. Emails are a significant mode of communication for scheduling services with patients.

In the EU and Switzerland, GDPR regulations significantly influence how patient data is collected, stored, and analyzed, emphasizing privacy and ethical considerations.

Understanding how a healthcare system works is the first step to avoid patient retention. Regular surveys are an important path to understand the patient journey mapping.

Integrating Healthcare Provider Perspectives

Engagement with healthcare providers (HCPs) enriches journey mapping.

Effective collaboration, guided by European Federation of Pharmaceutical Industries and Associations (EFPIA) codes and Swiss Pharma Code, ensures compliant communication strategies between pharma brands and HCPs, enhancing treatment adherence and patient trust.

As a healthcare organisation it is important to optimize the service delivery not only of the core providers but also the patient community.

Personalization and Empathy

Patient journey mapping prioritizes personalization and empathy, addressing unique patient circumstances.

It is crucial to have a clear goal in mind for the patient’s journey, whether it involves symptom treatment, receiving a diagnosis, or undergoing surgery.

Compliant engagement under GDPR and national regulations requires careful communication, fostering deeper patient satisfaction and effective adherence programs.

Each healthcare journey is an individual process and requires adaptable journey mapping techniques.

The patient’s perspective needs to be understood based on data collected. Artificial intelligence solutions, for example the AI integrated in the Screver amplify the precision and understanding of the patient experience.

Benefits of Patient Journey Mapping

Patient journey mapping provides tangible benefits within regulatory frameworks:

• Enhanced Understanding of Patient Needs:

Detailed patient insights drive improvements in service and compliance, aligning with regulatory bodies’ patient safety priorities. Specific information in patient care, such as the design of tools suited to particular needs, is crucial for achieving these goals.

• Facilitating Patient-Centric Innovations:

Incorporating patient feedback into product development ensures compliance with regulatory demands for patient-focused solutions.

For example, understanding how patients interact with health insurance portals can reveal insights into their expectations and experiences within the care journey, highlighting the importance of these interactions for improving patient experience.

• Supporting Value-Based Care:

Documented patient outcomes from journey mapping support submissions to regulators (EMA, Swissmedic), influencing reimbursement and market access decisions. It is a fact that each touchpoint is essential and contributes uniquely to the patient’s journey, ultimately affecting patient satisfaction and outcomes.

• Personalizing Patient Engagement:

Compliant segmentation of patient populations allows targeted strategies, improving treatment adherence and regulatory compliance. A health system is a comprehensive framework within which healthcare services are delivered and managed.

• Fostering Collaboration:

Journey mapping promotes stakeholder collaboration, including patient associations and regulatory agencies, ensuring compliant, patient-centric care. Effective collaboration requires systematic frameworks that encompass policies, processes, and technologies to facilitate better patient engagement, safety initiatives, and overall improvements in healthcare delivery.

Case Studies

• Engaging Healthcare Professionals:

Roche’s oncology patient journey mapping highlights regulatory-compliant strategies, optimizing HCP engagement under EMA guidelines and Swiss regulations. Participants were invited to provide responses to evaluations and feedback, ensuring comprehensive insights.

• A Mixed-Method Approach:

Combining qualitative and quantitative data aligns patient experiences with compliance requirements, demonstrated successfully by major pharma brands in Europe. The methodology used in qualitative research studies involves systematic processes and design frameworks, detailing specific methods for data collection and analysis to ensure the validity and reliability of the findings.

• Educational Materials Development:

Pharma brands like Real Chemistry and WhizAI leverage patient journey insights to create compliant educational materials addressing treatment side effects.

• Addressing Access Challenges:

Regulatory-driven patient journey mapping reveals treatment access barriers, informing compliant strategies that enhance patient support and market access. Health systems need to adopt patient journey mapping as a strategy to enhance the patient experience and retention in a consumer-driven healthcare environment.

• Modular Capability for Scalable Insights:

Real-World Data (RWD) initiatives, adhering to GDPR and local data regulations, facilitate scalable patient journey insights across multiple therapeutic areas. Understanding what strategies and processes are working well in healthcare is crucial for enhancing patient safety and engagement.

Challenges and Limitations

Navigating regulatory complexities is essential:

• Data Privacy Concerns:

GDPR and Swiss data protection laws require stringent privacy measures, influencing patient data collection and journey mapping activities. Specific instances and interactions that occurred in healthcare settings, such as key moments in patient care both in hospital and community environments, must be carefully analyzed to ensure compliance.

• Inadequate Support Programs:

Regulatory compliance mandates clear, empowering patient communications, avoiding overly medicalized language that hampers patient engagement.

• Technical and Logistical Hurdles:

Journey mapping must address practical regulatory challenges, including compliant scheduling and administration processes. Effective work among healthcare professionals and patients can enhance safety and improve experiences by fostering better collaboration and understanding.

• Emotional and Perceptual Disparities:

Understanding emotional patient responses must be aligned with compliant communication standards under EFPIA and Swiss Pharma Codes.

Future Trends

• Transformation in Customer Experience:

Emerging EU and Swiss regulations foster adoption of direct-to-patient models, enhancing compliant patient experiences through digital channels.

• Integration of AI and Data Analytics:

GDPR-compliant AI and analytics improve real-time patient journey insights, refining personalized patient engagement strategies.

• Enhanced Communication Channels:

Platforms specializing in customer experience journeys enable compliant, secure communication, vital for patient-centric interactions in regulated markets.

• Patient-Centric Approach:

Clearly communicating the use of patient data, complying with regulatory transparency requirements, builds trust and promotes effective patient engagement.

• Regulatory Considerations:

Continuous monitoring of EMA, Swissmedic, and national compliance requirements ensures successful patient journey mapping and market strategies.